đŸ» Faster Than The Bear

The 'limbo trade' strikes again, Meta gears up for big report after the close and more

Happy Thursday Zingernation!

-Aaron Bry And Nic Chahine

Plus, worried that your hair isn’t looking the same as when you were 18? Check out today’s partner, Hims.

And, crypto is so back. Billions of dollars are flowing into the new Bitcoin ETFs, driving prices to near all-time highs. Join thousands of engaged readers of Future Finance - our FREE digital assets newsletter.

MARKET SNAPSHOT

Yesterday: Another big day for the bulls, who were able to make some progress in their battle with the bears. The S&P 500 and Nasdaq Composite each closed up more than 1%, with the Dow lagging on the day.

On Our Radar: Tesla's leg up by more than 10% in pre-market trading is helping to propel tech stocks. Let’s see if the stock continues to trade higher, or if the trade will fade. Then, tonight, we will hear from Meta, IBM, Ford and more.

Plus: Looking to learn more about options? Join options masters Chris Capre and Matt Maley TONIGHT at 6:00 PM EST! Click here to claim your free ticket.

TOP STORY
Excited The Office GIF

Briefly: Tesla’s first-quarter earnings call triggered a 13% surge in after-hours trading, but analysts remain divided on the company’s near-term prospects.

Elon Delivers (Mostly): Future Fund‘s Gary Black said CEO Elon Musk delivered one of his best conference calls, despite the slight earnings miss. Incidentally, ahead of the earnings, the fund manager said he regretted not selling his firm’s entire Tesla holding after trimming it from 12.2% in September 2022 to 2.7%.

Quoted: “We were pleased that TSLA confirmed that not only was the more affordable next-gen vehicle not canceled, [but] TSLA appears to have accelerated the start of production (previously 2025 year-end) to ‘early 2025,'” he said.

So: Black found other positives, including a higher-than-expected gross margin and reassurances about 2024 volumes exceeding 2023. He did acknowledge the inclusion of unspecified one-time revenue recognition for FSD.

Click here for the full scoop.

PRESENTED BY TRADESMITH

There's been a lot of buzz surrounding A.I. over the past year


Most of it is just hype and speculation.

Because it's going to have a very real impact on the lives of everyday Americans...

Billion-dollar fund manager Louis Navellier recently recorded an urgent message going over all the details.

FIVE ZINGERS

Mailbox Money: Warren Buffett is averaging nearly $3 million a day on dividends in this financial stock.

Everything’s Bigger In Texas: Texas Instruments reported earnings yesterday, and the stock is closing higher. Let me get my TI calculator out to break down the numbers.

Gains ‘R Us: Toy maker Hasbro delivered some up-beat earnings and the stock is trading higher by nearly 10% this morning. Here’s what’s going on.

Daily Double: Donald Trump got a nice bonus, earnings a million extra shares of $DJT through a performance-based compensation plan.

Turbulence Or Smooth Cruising?: Boeing’s stock is catching a bid after reporting earnings that cleared the Street’s low bar. But will it last?

ONE FOR THE ROAD
Jimmy Fallon Please GIF by The Tonight Show Starring Jimmy Fallon

What Happened: Meta has set a goal of buying 350,000 Nvidia Corp H100 GPUs by 2024 to power its AI ambitions, but that was not Mark Zuckerberg's original intention.

What Happened: Zuckerberg revealed that Meta's massive $1 billion bet on Nvidia's H100 GPUs was originally meant to be used for a different product, not AI.

Inside Scoop: In a recent episode on Dwarkesh Patel's podcast, Zuckerberg spilled the beans on something previously unknown – those 350,000 Nvidia H100 GPUs were to help make Instagram Reels better, not to help make Meta a leading AI company.

The Plans: But how did Zuckerberg even know Meta would need $1 billion worth of GPUs? Zuckerberg explains that Instagram Reels is what made the company take the plunge. "It was because we were working on Reels." He explained that Meta needed more GPUs to "train the models" behind Reels recommendations.

Click here to read more.

PRESENTED BY HIMS

Hims offers award-winning hair loss treatments that truly work. Available in a serum, spray, pill, or chew — whichever fits your routine.

You can trust that all Hims products are made with doctor-trusted, clinically proven ingredients. And the process is simple and 100% online.

Ready to find out what Hims can do for you? Complete their intake form and a medical provider will determine if treatment is right for you. If prescribed, your medication ships for free!

Based on separate individual studies of topical and oral finasteride and minoxidil. Hair Hybrids are compounded products and have not been approved by the FDA. The FDA does not verify the safety or effectiveness of compounded drugs. Restrictions apply, see website for full details. Prescription products require an online consultation with a healthcare provider who will determine if a prescription is appropriate. *Actual price to customer will depend on product and subscription plan purchased.